Biomunex Pharmaceuticals
Records under this name other than the patents Biomunex Pharmaceuticals holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Showing 1 to 3 of 3 · Back to Biomunex Pharmaceuticals
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| 17/791,549 | Multispecific Antibodies That Bind Both Mait and Tumor Cells held by Biomunex Pharmaceuticals, Institut Curie and Inserm (Institut National de la Santé et de la Recherche Médicale) Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/589,695 | Polypeptide Linker for Preparing Multispecific Antibodies Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/842,834 | Bispecific Antibodies Binding to HER-3 and to Either HER-2 or Egfr held by Biomunex Pharmaceuticals, Institut National de la Sante et de la Recherche Medicale, Université de Montpellier and Institut Régional du Cancer de Montpellier Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |